Definium Therapeutics is seeking a Director of Late‑Stage Clinical Strategy to shape end‑to‑end Expanded Access and late‑stage programs across our portfolio. You will partner with Clinical Development, Regulatory, and Operations to ensure feasibility, regulatory readiness, and lifecycle alignment while guiding external collaborations with investigators and partners.
You will drive long‑term evidence generation, real‑world data plans, and post‑approval commitments, balancing strategic vision with
#J-18808-LjbffrDirector, Late-Stage Clinical Strategy & Expanded Access in myrtle point at Unknown Company
This position is listed as full time and onsite.